Filana Therapeutics (FLNA) Invested Capital (2023 - 2024)
Filana Therapeutics (FLNA) posted Invested Capital of $144.0 million for Q1 2024, up 4.73% on a QoQ basis from $137.5 million in Q4 2023.
Powered by 
Analysis
Filana Therapeutics (FLNA) Invested Capital (2023 - 2024) Analysis & Trends
Filana Therapeutics has reported Invested Capital for 2 years, with the latest figure at $144.0 million in Q1 2024.
- On a quarterly basis, Invested Capital changed N/A year-over-year to $144.0 million in Q1 2024; TTM through Mar 2024 was $144.0 million, a N/A change from a year earlier, with the FY2023 full-year figure at $137.5 million, changed N/A from the prior year.
- Invested Capital was $144.0 million for Q1 2024 at Filana Therapeutics, up from $137.5 million in the prior quarter.
- The five-year high for Invested Capital was $144.0 million in Q1 2024, with the low at $137.5 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 74.44 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 40.49 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 33.70 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 7.35 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.94 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Filana Therapeutics | 38.14 Mn | 38.14 Mn | - | - |